1-(14-{[2-(2,6-Dioxo-3-piperidinyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}-2-oxo-6,9,12-trioxa-3-azatetradec-1-yl)-N-[5-({[5-(2-methyl-2-propanyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2 -yl]-4-piperidinecarboxamide(CAS: 2139287-33-3)

Regulatory guidelines for [compound name] (CAS: 2139287-33-3) include the Globally Harmonized System (GHS) for classification and labeling, REACH regulations in the EU, and FDA/EPA requirements for pharmaceutical and environmental safety. Manufacturers and handlers must comply with these standards to ensure safe handling and disposal.

In synthesis, alternatives to [compound name] (CAS: 2139287-33-3) include similar chemical compounds such as piperidine derivatives and thiazole analogs. These alternatives can be used based on the specific needs of the synthesis process, often offering comparable reactivity but with different properties or advantages.

The market for [compound name] (CAS: 2139287-33-3) is driven by its applications in pharmaceuticals and research. Recent trends show a growing interest in its potential for therapeutic use, particularly in anti-inflammatory and antiviral treatments. Research is focusing on its mechanism of action and optimizing its properties.

Waste containing [compound name] (CAS: 2139287-33-3) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration or chemical treatment methods are commonly used. Environmental protection measures include ensuring no hazardous materials are released into the environment and following local and international environmental regulations.